Benzinga's Volume Movers

shares climbed 40.52 percent to $18.90. The volume of Collegium Pharmaceutical shares traded was 4952 percent higher than normal. Collegium Pharmaceutical reported that the FDA Advisory Committees have unanimous recommended the approval of Xtampza ER.

surged 8.57 percent to $53.69. The volume of Solera Holdings shares traded 4194 percent higher than normal. Solera agreed to be acquired by an affiliate of Vista Equity Partners for around $3.74 billion in cash.

shares moved up 8.05 percent to $18.65. The volume of Aquinox Pharmaceuticals traded was 236 percent higher than normal. Aquinox Pharmaceuticals shares have jumped 139.72 percent over the past 52 weeks, while the S&P 500 index has declined 1.23 percent in the same period.

shares rose 12 percent to $16.93. The volume of Chico's FAS shares traded was 86 percent higher than normal. Chico's FAS is considering a sale of the company, according to sources reported by Bloomberg late Friday. Sycamore Partners is said to be one of the bidders.